Diasorin SpA (MIL:DIA) ROE % Adjusted to Book Value : 4.03% (As of Jun. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Diasorin SpA ROE % Adjusted to Book Value?

Diasorin SpA's ROE % for the quarter that ended in Jun. 2024 was 12.37%. Diasorin SpA's PB Ratio for the quarter that ended in Jun. 2024 was 3.07. Diasorin SpA's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was 4.03%.

Diasorin SpA ROE % Adjusted to Book Value Historical Data

The historical data trend for Diasorin SpA's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diasorin SpA ROE % Adjusted to Book Value Chart

Diasorin SpA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

3.04

2.82

3.99

3.64

3.24

Diasorin SpA Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															2.22	3.83	3.95	4.03	-

Competitive Comparison of Diasorin SpA's ROE % Adjusted to Book Value

For the Diagnostics & Research subindustry, Diasorin SpA's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Diasorin SpA's ROE % Adjusted to Book Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Diasorin SpA's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Diasorin SpA's ROE % Adjusted to Book Value falls into.

Diasorin SpA ROE % Adjusted to Book Value Calculation

Diasorin SpA's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	10.46%	/	3.23
	=	3.24%

Diasorin SpA's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	12.37%	/	3.07
	=	4.03%

Diasorin SpA ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Diasorin SpA's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Diasorin SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (MIL:DIA) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

DIAm:UK 0GZX:UK 34D:Germany DIAS:Austria

Address

Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040

Website

https://www.diasoringroup.com

DiaSorin, headquartered in Italy, is a global provider of in vitro diagnostics, or IVD, which refers to testing done on samples taken from the human body, such as blood and tissue. DiaSorin produces and markets testing reagent kits for immunodiagnostics (about 65% of total sales) and molecular diagnostics (about 20%) and has a total installed base of about 9,000 diagnostic systems. Instruments and other revenue contribute about 15% of total sales. DiaSorin's largest market in 2023 was North America, which accounted for 48% of non-covid revenue, followed by Europe (35%) and the Rest of the World (18%).